Metabolomics of lung cancer: Analytical platforms and their applications-Reference-Cited by-同舟云学术

Metabolomics of lung cancer: Analytical platforms and their applications

Published:2019-12-10 Issue:1 Volume:43 Page:120-133
ISSN:1615-9306
Container-title:Journal of Separation Science
language:en
Short-container-title:J. Sep. Sci.

Author:

Noreldeen Hamada A. A.¹²³,Liu Xinyu¹^ORCID,Xu Guowang¹

Affiliation:

1. CAS Key Laboratory of Separation Science for Analytical ChemistryDalian Institute of Chemical PhysicsChinese Academy of Sciences Dalian P. R. China

2. University of Chinese Academy of Sciences Beijing P. R. China

3. Marine Chemistry LabMarine Environment DivisionNational Institute of Oceanography and Fisheries Hurghada Egypt

Funder

National Basic Research Program of China

National Natural Science Foundation of China

Publisher

Wiley

Subject

Filtration and Separation,Analytical Chemistry

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jssc.201900736

Reference121 articles.

1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

2. Small-cell lung cancer

3. Differences in Epidemiology, Histology, and Survival Between Cigarette Smokers and Never-Smokers Who Develop Non-small Cell Lung Cancer

4. A review of metabolism-associated biomarkers in lung cancer diagnosis and treatment

5. RETRACTED: 100 years of lung cancer

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting Dual Immune Checkpoints PD‐L1 and HLA‐G by Trispecific T Cell Engager for Treating Heterogeneous Lung Cancer;Advanced Science;2024-09-05

2. Plasma Metabolite Profiling in the Search for Early-Stage Biomarkers for Lung Cancer: Some Important Breakthroughs;International Journal of Molecular Sciences;2024-04-25

3. A metabolomics study on carcinogenesis of ground-glass nodules;Cytojournal;2024-03-18

4. Non-targeted metabolomics study for discovery of hepatocellular carcinoma serum diagnostic biomarker;Journal of Pharmaceutical and Biomedical Analysis;2024-02

5. Targeting metabolic reprogramming in hepatocellular carcinoma to overcome therapeutic resistance: A comprehensive review;Biomedicine & Pharmacotherapy;2024-01